Evidence map›Paper›PMID 41079532›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Diagnosis, Treatment Patterns and Eradication Success for

Changqin Xu, Wensheng Pan, Yan Zhao, Pengfei Li, Fang Zhou, Li Xie, Hongwei Xu

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Diagnosis, Treatment Patterns and Eradication Success forJGH open : an open access journal of gastroenterology and hepatology · 2025
    Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Changqin XuDepartment of Gastroenterology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China.
Wensheng PanDepartment of Gastroenterology Zhejiang Provincial People's Hospital Hangzhou China.ORCID https://orcid.org/0000-0002-2347-1695
Yan ZhaoDepartment of Gastroenterology Shanghai Tenth People's Hospital Shanghai China.
Pengfei LiTDC Takeda APAC Biopharmaceutical R&D Ltd Shanghai China.
Fang ZhouChina Medical Team, Takeda (China) International Trading Co. Ltd. Shanghai China.
Li XieChina Medical Team, Takeda (China) International Trading Co. Ltd. Shanghai China.
Hongwei XuDepartment of Gastroenterology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China.ORCID https://orcid.org/0000-0001-8118-5307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: In Mainland China, Methods and Results: This retrospective, observational, real-world study used data from electronic medical records databases from three hospitals in Shanghai City, Shandong Province, and Zhejiang Province. Patients (≥ 18 years) with an Conclusions: Treatment of

Indexed as

bismuth quadruple therapyChinaHelicobacter pylorireal world

Identifiers

PMID41079532
PMCPMC12514013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.